1. Home
  2. HUBB vs ZBH Comparison

HUBB vs ZBH Comparison

Compare HUBB & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hubbell Inc

HUBB

Hubbell Inc

HOLD

Current Price

$536.46

Market Cap

23.5B

Sector

Technology

ML Signal

HOLD

Logo Zimmer Biomet Holdings Inc.

ZBH

Zimmer Biomet Holdings Inc.

HOLD

Current Price

$94.75

Market Cap

19.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUBB
ZBH
Founded
1888
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.5B
19.5B
IPO Year
2004
2001

Fundamental Metrics

Financial Performance
Metric
HUBB
ZBH
Price
$536.46
$94.75
Analyst Decision
Buy
Hold
Analyst Count
8
20
Target Price
$517.88
$104.56
AVG Volume (30 Days)
462.4K
1.8M
Earning Date
04-30-2026
04-28-2026
Dividend Yield
1.09%
1.01%
EPS Growth
15.10
N/A
EPS
16.54
3.55
Revenue
$5,844,600,000.00
$8,231,500,000.00
Revenue This Year
$10.34
$4.97
Revenue Next Year
$5.47
$3.75
P/E Ratio
$31.51
$26.71
Revenue Growth
3.84
7.20
52 Week Low
$325.08
$84.59
52 Week High
$548.97
$108.29

Technical Indicators

Market Signals
Indicator
HUBB
ZBH
Relative Strength Index (RSI) 60.51 58.38
Support Level $416.52 $93.29
Resistance Level N/A $95.31
Average True Range (ATR) 14.53 1.99
MACD 3.06 0.59
Stochastic Oscillator 82.24 69.89

Price Performance

Historical Comparison
HUBB
ZBH

About HUBB Hubbell Inc

Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, in electrical substations, and in commercial and industrial buildings. The company's primary operations are in the United States, where around 90% of revenue is derived.

About ZBH Zimmer Biomet Holdings Inc.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Share on Social Networks: